William Blair research analyst Margaret Kaczor Andrew was quoted in a Washington Post article centered on the use of continuous coverage glucose monitors by more than just their manufacturers’ intended audience—diabetics—and the impact on investments in those companies.

“Now both companies [Dexcom and Abbott] are targeting one of the arguably largest medical technology markets we have ever seen,” Kaczor Andrew wrote in her note to investors that was cited by the publication.